BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35884779)

  • 1. Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes.
    Ardeshna DR; Rangwani S; Cao T; Pawlik TM; Stanich PP; Krishna SG
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.
    Skaro M; Nanda N; Gauthier C; Felsenstein M; Jiang Z; Qiu M; Shindo K; Yu J; Hutchings D; Javed AA; Beckman R; He J; Wolfgang CL; Thompson E; Hruban RH; Klein AP; Goggins M; Wood LD; Roberts NJ
    Gastroenterology; 2019 May; 156(6):1905-1913. PubMed ID: 30716324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.
    Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A
    J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?
    Bartsch DK; Dietzel K; Bargello M; Matthaei E; Kloeppel G; Esposito I; Heverhagen JT; Gress TM; Slater EP; Langer P
    Fam Cancer; 2013 Mar; 12(1):89-96. PubMed ID: 23179793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.
    Matthaei H; Norris AL; Tsiatis AC; Olino K; Hong SM; dal Molin M; Goggins MG; Canto M; Horton KM; Jackson KD; Capelli P; Zamboni G; Bortesi L; Furukawa T; Egawa S; Ishida M; Ottomo S; Unno M; Motoi F; Wolfgang CL; Edil BH; Cameron JL; Eshleman JR; Schulick RD; Maitra A; Hruban RH
    Ann Surg; 2012 Feb; 255(2):326-33. PubMed ID: 22167000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma.
    Tanaka M
    Pancreas; 2018; 47(5):544-550. PubMed ID: 29702531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.
    Smith LA; Mckay CJ
    Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?
    Wang Y; Cuggia A; Chen YI; Parent J; Stanek A; Denroche RE; Zhang A; Grant RC; Domecq C; Golesworthy B; Shwaartz C; Borgida A; Holter S; Wilson JM; Chong G; O'Kane GM; Knox JJ; Fischer SE; Gallinger S; Gao ZH; Foulkes WD; Waschke KA; Zogopoulos G
    J Natl Compr Canc Netw; 2022 Jun; 20(6):663-673.e12. PubMed ID: 35714671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
    Smith LA; McKay CJ
    Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.
    Sohn TA; Yeo CJ; Cameron JL; Iacobuzio-Donahue CA; Hruban RH; Lillemoe KD
    Ann Surg; 2001 Sep; 234(3):313-21; discussion 321-2. PubMed ID: 11524584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.
    Choi MG; Kim SW; Han SS; Jang JY; Park YH
    Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Unresected Intraductal Papillary Mucinous Neoplasms of the Pancreas to Cancer: A Systematic Review and Meta-analysis.
    Choi SH; Park SH; Kim KW; Lee JY; Lee SS
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1509-1520.e4. PubMed ID: 28342950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
    Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
    World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.
    Werner J; Fritz S; Büchler MW
    Nat Rev Gastroenterol Hepatol; 2012 Mar; 9(5):253-9. PubMed ID: 22392299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
    Adsay NV; Longnecker DS; Klimstra DS
    Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.